Toronto, Ontario–(Newsfile Corp. – December 16, 2025) – Prophecy DeFi Inc. (CSE: PDFI) (“Prophecy DeFi” or the “Company“) is pleased to announce that it has filed articles of amendment to consolidate its issued and outstanding common shares (each, a “Common Share“) on the basis of fifty (50) pre-consolidation Common Shares for one (1) post-consolidation Common Share (the […]
New Glasgow, Nova Scotia–(Newsfile Corp. – December 16, 2025) – Crombie Real Estate Investment Trust (TSX: CRR.UN) (“Crombie”) today announced a distribution of $0.07500 per Unit for the period from December 1, 2025, to and including December 31, 2025. The distribution will be payable on January 15, 2026, to Unitholders of record as at December 31, 2025.
(NASDAQ:EVTV), HOUSTON and NEWPORT BEACH, Calif., Dec. 16, 2025 (GLOBE NEWSWIRE) — via IBN — Envirotech Vehicles, Inc. (NASDAQ:EVTV) (“EVTV” or the “Company”) today announced that it has entered into an exclusive strategic acquisition framework with AZIO AI Corporation (www.azioai.ai), a rapidly scaling AI infrastructure company delivering high-performance compute, modular data-center solutions, and applied AI
(NASDAQ:PVLA), Fast Track designation designed to facilitate the development, and expedite the review, of drugs to treat serious conditions and fill an unmet need With Fast Track designation, QTORIN(TM) rapamycin for angiokeratomas may be eligible for Accelerated Approval and Priority Review in the future, if applicable criteria are met Palvella plans to initiate a Phase
WOBURN, Mass., Dec. 16, 2025 (GLOBE NEWSWIRE) — Vertero Therapeutics, a clinical-stage biotechnology company breaking barriers in neurodegenerative disease treatment, today announced the appointment of R. Scott Greer as the new chair of its Board of Directors. Mr. Greer is a veteran in the life sciences industry with more than 30 years' experience as an
(NASDAQ:RGEN), WALTHAM, Mass., Dec. 16, 2025 (GLOBE NEWSWIRE) — Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced the launch of three new high-performance chromatography resins: AVIPure(R) HiPer(TM) AAV9 and AVIPure(R) HiPer(TM) AAV8 affinity resins, along with HiPer(TM) QA anion exchange resin, expanding the company's growing proteins portfolio and reinforcing
— Valour adds Solana exposure: DeFi Technologies' subsidiary Valour has received approval from B3 to list Valour Solana (VSOL), expanding its Brazilian digital asset ETP lineup beyond Bitcoin, Ethereum, XRP, and Sui, and giving investors BRL-denominated, locally listed exposure to Solana via their existing brokerage and custody rails. — Deepening Brazil's product suite: VSOL is
Achieved target product profile on the primary endpoint, with a mean percent reduction in SALT score at 36 weeks of 28.2% in the 24 µg/kg arm versus 11.2% in placebo Mean percent reduction in SALT scores at 36 weeks was 30% for both treatment arms versus 6% for placebo, achieving statistical significance (p<0.05) when excluding
Combined donations will help pair more lifesaving Service Dogs with Veterans living with PTSD, traumatic brain injury and/or military sexual trauma. Starwood Pet Travel, a globally recognized pet-relocation company and veteran-owned business, announced today that it has raised a combined $7,600 for K9s For Warriors through two recent initiatives: its Veterans Day campaign held November
OneStep's Clinically Validated Mobility Intelligence Technology to Integrate into Zimmer Biomet's mymobility® Care Management Platform to Further Enhance Recovery Monitoring Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, and OneStep, the FDA-listed digital fall prevention and mobility intelligence platform, today announced an exclusive collaboration agreement aimed at delivering the orthopedic